(Q71024635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

0 references

1 reference

title

Treatment of viral myocarditis with focus on captopril (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

S H Rezkalla

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S Raikar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R A Kloner

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

634-637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

Management strategies in viral myocarditis

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

A Mouse Model of Transmural Myocardial Necrosis Due to Coxsackievirus B4: Observations over 12 Months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

An experimental model of acute and subacute viral myocarditis in the pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Treatment of viral myocarditis with ribavirin in an animal preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus-induced myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Immunosuppressive therapy in patients with congestive cardiomyopathy and myocardial uptake of gallium-67

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Diagnosis and classification of myocarditis by endomyocardial biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

The effects of cyclosporine on acute murine Coxsackie B3 myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Effects of prednisolone on acute viral myocarditis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Effect of metoprolol in acute coxsackievirus B3 murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Verapamil ameliorates the clinical and pathological course of murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Effects of polyethylene glycol conjugated superoxide dismutase on coxsackievirus B3 myocarditis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989320-4

10.1016/S0002-9149(97)89320-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610616%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference